Quantum-Si incorporated (QSI)
NGM · Healthcare · Medical Devices
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 552K | 451K | 258K | 344K |
| Gross Profit | 194K | 122K | 74K | 172K |
| Operating Income | (24.4M) | (21.1M) | (24.1M) | (25.6M) |
| Net Income | (35.7M) | (17.6M) | (21.7M) | (23.5M) |
| Diluted EPS | $-0.17 | $-0.08 | $-0.10 | $-0.11 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 1.1M | 3.1M | 2.4M |
| Gross Profit | 0.00 | 488K | 1.6M | 1.2M |
| Operating Income | (114.4M) | (111.2M) | (108.6M) | (97.4M) |
| Net Income | (132.4M) | (96.0M) | (101.0M) | (101.3M) |
| Diluted EPS | $-0.95 | $-0.68 | $-0.71 | $-0.51 |